Abstract:Metabolic syndrome (MetS) is defined as a cluster of glucose intolerance, hypertension, dyslipidemia, and central obesity with insulin resistance. The role of gut microbiota in metabolic disorders is increasingly considered. To investigate the effects of probiotic supplements and hypocaloric high fiber regimen on MetS in obese Egyptian women. A longitudinal follow-up intervention study included 58 obese Egyptian women, with a mean age of 41.62 ± 10.70 years. They were grouped according to the criteria of MetS into 2 groups; 23 obese women with MetS and 35 ones without MetS. They followed a hypocaloric high fiber regimen weight loss program, light physical exercise, and received a probiotic supplement daily for 3 months. For each participating woman, blood pressure, anthropometric measurements, basal metabolic rate (BMR), dietary recalls, laboratory investigations, and microbiota analysis were acquired before and after 3 months of follow-up After intervention by the probiotic and hypocaloric high fiber regimen and light exercise, reduction ranged from numerical to significant difference in the anthropometric parameters, blood pressure, and BMR was reported. All the biochemical parameters characterized by MetS decreased significantly at p ≤ 0.05–0.01. Before the intervention, results revealed abundant of Bacteroidetes bacteria over Firmicutes with a low Firmicutes/Bacteroidetes ratio. After the intervention, Log Lactobacillus, Log Bifidobacteria, and Log Bacteroidetes increased significantly in both groups, while Log Firmicutes and the Firmicutes/Bacteroidetes Ratio revealed a significant decrease. In conclusion, this study's results highlight a positive trend of probiotics supplementation with hypocaloric high-fiber diets in amelioration of the criteria of the Mets in obese Egyptian women.

What problem does this paper attempt to address?

### The problems the paper attempts to solve This paper aims to explore the effects of probiotic supplements and a low - calorie, high - fiber diet on metabolic syndrome (MetS) in obese Egyptian women. Specifically, the objective of the study is to evaluate the effectiveness of this dietary therapy in reducing body weight, improving related metabolic disorders, and gut microbiota dysbiosis. #### Background and problem statement Metabolic syndrome (MetS) is a complex disease caused by multiple interrelated factors, mainly manifested as abnormal glucose tolerance, hypertension, dyslipidemia, and central obesity, accompanied by insulin resistance. Obesity is the most common precursor factor of metabolic syndrome, so the treatment of obesity may help to control and manage metabolic syndrome. In recent years, more and more studies have shown that the gut microbiota plays an important role in metabolic disorders. Gut dysbiosis may lead to damage to the gut barrier, triggering a low - grade inflammatory response in the body, and then causing insulin resistance through metabolites that change host metabolism and hormone release, forming a vicious cycle and promoting the development of metabolic syndrome. #### Research objectives The main objective of this study is to investigate the effects of probiotic supplements and a low - calorie, high - fiber diet on metabolic syndrome in obese Egyptian women. Specific objectives include: 1. **Evaluating weight loss**: To study whether probiotic supplements and a low - calorie, high - fiber diet can effectively reduce body weight. 2. **Improving metabolic parameters**: To evaluate the effects of these interventions on metabolic parameters such as blood pressure, blood glucose, and blood lipids. 3. **Adjusting gut microbiota**: To analyze the effects of these interventions on the gut microbiota, especially the changes in the number of beneficial bacteria (such as Lactobacillus and Bifidobacterium) and their effects on the Firmicutes/Bacteroidetes ratio. #### Method overview This study is a longitudinal follow - up intervention study. A total of 58 obese Egyptian women with an average age of 41.62 ± 10.70 years were included. The participants were divided into two groups: 23 obese women with metabolic syndrome and 35 obese women without metabolic syndrome. All participants underwent a 3 - month intervention, including a low - calorie, high - fiber diet plan, mild physical exercise, and daily probiotic supplement intake. Before and after the study, the blood pressure, anthropometric parameters, basal metabolic rate, diet records, laboratory test results, and gut microbiota analysis of the participants were measured respectively. #### Results After the intervention, the study found that: - Anthropometric parameters such as body weight, body mass index (BMI), and waist circumference were significantly reduced. - Blood pressure and basal metabolic rate were significantly decreased. - Blood glucose, insulin concentration, and HOMA - IR (insulin resistance index) were significantly decreased. - In the lipid profile, low - density lipoprotein cholesterol (LDL - C) was significantly decreased, and high - density lipoprotein cholesterol (HDL - C) was significantly increased. - In the gut microbiota, Log Lactobacillus, Log Bifidobacteria, and Log Bacteroidetes were significantly increased, while Log Firmicutes and the Firmicutes/Bacteroidetes ratio were significantly decreased. #### Conclusions The study shows that probiotic supplements combined with a low - calorie, high - fiber diet can effectively improve the symptoms of metabolic syndrome in obese Egyptian women and regulate the gut microbiota at the same time. This comprehensive intervention method may provide new ideas for the management and prevention of metabolic syndrome. ### Formula summary 1. **Insulin resistance index (HOMA - IR)**: \[ \text{HOMA - IR}=\frac{\text{Fasting blood glucose (mg/dl)}\times\text{Fasting insulin (\(\mu\)IU/ml)}}{405} \] 2. **Low - density lipoprotein cholesterol (LDL - C) calculation formula (Friedewald formula)**: \[ \text{LDL - C}=\text{Total cholesterol}-\frac{\text{Triglycerides}}{5}+\text{High - density lipoprotein cholesterol} \] Through the above - mentioned study, the author hopes to provide a safe and effective non - drug intervention scheme for the treatment of metabolic syndrome, especially for obese people.

Gut dysbiosis is linked to metabolic syndrome in obese Egyptian women: potential treatment by probiotics and high fiber diets regimen

Brief overview of dietary intake, some types of gut microbiota, metabolic markers and research opportunities in sample of Egyptian women

Effect of weight loss program using prebiotics and probiotics on body composition, physique, and metabolic products: longitudinal intervention study

The gut microbial community in metabolic syndrome patients is modified by diet

The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian females

Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome

Gut Microbiota As a Potential Target for Treatment of Polycystic Ovary Syndrome

Multivariate Analysis and Correlation Study Shows the Impact of Anthropometric and Demographic Variables on Gut Microbiota in Obese Egyptian Children

Gut Microbiota and Metabolic Syndrome: Relationships and Opportunities for New Therapeutic Strategies

The Prospect of Probiotics to Treat Metabolic Syndrome

Harnessing the Power of the Gut Microbiome: A Review of Supplementation Therapies for Metabolic Syndrome

Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome

Probiotics and postbiotics: focus on metabolic syndrome

The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials

The impact of using probiotics on metabolic disorders of women with polycystic ovary syndrome

New therapy for metabolic syndrome: Gut microbiome supplementation

Modulation of Gut Microbiota through Low-Calorie and Two-Phase Diets in Obese Individuals

Impact of Dietary Patterns and Serum Amino Acid Profile on Metabolic Syndrome Development in Mexican Women with Polycystic Ovary Syndrome

Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial

The role of gut microbiota in the development of metabolic syndrome

Appetite sensation improvement by synbiotic supplementation in patients with metabolic syndrome: A randomized controlled clinical trial